Don't want ads? Subscribe or login now.

Health Tech Co. Overstated AI Capabilities, Investor Suit Says

By Katryna Perera · June 13, 2025, 8:00 PM EDT

Health technology company Tempus AI Inc. and two of its executives face a shareholder class action over claims the company misrepresented its artificial intelligence capabilities, the value of its contracts and...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

Shouse v. Tempus AI, Inc. et al

Case Number

1:25-cv-06534

Court

Illinois Northern

Nature of Suit

850 Securities/Commodities

Date Filed

June 12, 2025

Recent Articles By Katryna

October 17, 2025
Acadia Investors Score Partial Win In Fraud Class Action
September 18, 2025
Cytokinetics Investor Sues Over Heart Drug Approval Claims
September 08, 2025
FibroGen To Pay SEC $1.25M Over Drug Mistatements
September 05, 2025
Vein Tech Maker Wants Suit Over DOJ Kickback Probe Tossed
August 28, 2025
2nd Circ. Affirms Hedge Fund Win In $87M Short-Swing Suit
August 28, 2025
Kimberly-Clark To Pay $40M Over Adulterated Surgical Gowns
August 20, 2025
Ohio Justices Free Bank From $77M Guaranty Disclosure Duty
August 19, 2025
Sotera Urges 6th Circ. To Toss Investors' Toxic Gas Suit
August 11, 2025
Judge OKs Becton Dickinson's $9M Investor Settlement
August 07, 2025
BioPharma Co.'s $15M Deal Over Ruined J&J Vaccines OK'd